ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets
Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations
ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...
ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services
Chicago, IL, August 23, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical, quality and compliance, medical information, and pharmacovigilance services and solutions...
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook A Customer-Centric Approach to Clinical Research Solutions ProPharma Group is honored to be named Top 10 CRO 2022 by Pharma Tech Outlook...
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards: ProPharma Group is honored to be awarded "Best Pharmaceutical Regulatory & Compliance...
ProPharma Group Announces the Acquisition of M Squared Associates
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory and quality consulting firm...
ProPharma Group Announces the Acquisition of Pharmica Consulting
ProPharma Group Announces the Acquisition of Pharmica Consulting: ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Pharmica Consulting, a life science...
ProPharma Group and The Planet Group Announce Executive Leadership Changes and Branding of Combined Company
ProPharma Group, a portfolio company of Odyssey Investment Partners, is the global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical,...
ProPharma Group Announces the Acquisition of iSafety Systems
ProPharma Group Announces the Acquisition of iSafety Systems: ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of iSafety Systems. Headquartered in...
Former Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, Joins NDA Partners as Expert Consultant
NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...
